The New Neurotoxin Dosing Paradigm
Dr. Michael Gold discusses how the expected approval for long-lasting newcomer, DAXI, is pushing the envelope for current FDA-approved neurotoxins to examine higher doses. “DAXI is changing a lot of things in the in the toxin space,” says Michael Gold, MD, FAAD. “DAXI will get an approval, most likely, for the longest acting toxin that […]